Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2021-01-01
2029-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Enteral Nutrition and Corticosteroid on Intestinal Flora in Induction Remission of Crohn Disease in Adult
NCT02056418
Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
NCT05387031
Surgery Versus Biologics for Stricturing CD--a RCT
NCT05421455
Phenotyping of Adult Crohn's Focusing on Sarcopenia
NCT05572203
Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn's Disease
NCT04135027
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with stricturing Crohn's diseases
Patients with stricturing Crohn's diseases
treat these patients with biologics
treat these patients with biologics
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
treat these patients with biologics
treat these patients with biologics
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no surgical indication
* patients with asymptomatic penetrating diseases
* written consent acquired
Exclusion Criteria
* patients with symptomatic penetrating diseases
* contraindication of biologics
* anticipating other trial
16 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jinling Hospital, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhu Weiming
Senior Doctor, Principal Investigator, Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Weiming wm Zhu, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Jinling Hospital, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of General Surgery, Jinling hosptal,Medical School of Nanjing University
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JinlingH20221203
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.